PTC Therapeutics Inc. (PTCT)
NASDAQ: PTCT
· Real-Time Price · USD
48.82
0.12 (0.25%)
At close: Aug 15, 2025, 3:59 PM
48.92
0.20%
After-hours: Aug 15, 2025, 07:52 PM EDT
PTC Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 1.02B | 1.48B | 779.71M | 526M | 654.78M | 548.36M | 594M | 165.16M | 208.39M | 167.5M | 279.83M | 104.42M | 158.16M | 144.18M | 773.38M | 189.82M | 177.35M | 146.63M |
Short-Term Investments | 971.76M | 546.95M | 359.99M | 487.36M | 438.51M | 336.46M | 282.74M | 129.65M | 129.55M | 118.81M | 130.87M | 184.01M | 347.39M | 443.62M | 583.66M | 678.13M | 769.73M | 841.77M |
Long-Term Investments | 15.68M | n/a | n/a | 13.79M | 13.76M | 16.27M | 16.28M | 16.25M | 16.1M | 16.1M | n/a | 16.09M | 16.09M | 7.5M | 7.5M | 7.5M | 7.5M | 7.5M |
Other Long-Term Assets | 6.1M | 21.42M | 20.7M | 11.55M | 9.34M | 8.28M | 19.96M | 34.74M | 35.65M | 47.88M | 48.58M | 55.12M | 60.34M | 36.9M | 219.99M | 58.03M | 61.91M | 67.66M |
Receivables | 196.13M | 210.5M | 158.55M | 199.98M | 187.15M | 198.46M | 161.02M | 165.72M | 177.5M | 201.87M | 155.61M | 124.46M | 135.94M | 141.29M | 110.45M | 96.64M | 78.8M | 94.12M |
Inventory | 34.06M | 21.68M | 23.19M | 35.67M | 31.83M | 30.06M | 30.58M | 35.75M | 32.02M | 26.65M | 21.81M | 14.81M | 15M | 15.28M | 15.86M | 15.61M | 16.44M | 16.23M |
Other Current Assets | 53.53M | 57.05M | 44.09M | 32.55M | 45.64M | 55.41M | 150.29M | 1.4M | 42.23M | 98.57M | 105.66M | n/a | 38.18M | 29.65M | 54.68M | 30.94M | 23.91M | 23.6M |
Total Current Assets | 2.27B | 2.32B | 1.37B | 1.28B | 1.36B | 1.17B | 1.22B | 540.36M | 589.69M | 613.39M | 693.78M | 517.26M | 694.68M | 774.01M | 773.38M | 1.01B | 1.07B | 1.12B |
Property-Plant & Equipment | 113.35M | 116.78M | 117.66M | 122.64M | 123.12M | 183.97M | 178.99M | 179.1M | 178.81M | 179.02M | 175.02M | 171.79M | 206.55M | 135.18M | 130.01M | 125.05M | 123.6M | 119.5M |
Goodwill & Intangibles | 226.15M | 200.79M | 201.13M | 412.71M | 412.22M | 412.38M | 461.84M | 505.68M | 533.97M | 768.55M | 788.23M | 832.23M | 842.5M | 846.01M | 807.18M | 805.6M | 799.42M | 794.91M |
Total Long-Term Assets | 361.28M | 338.98M | 339.49M | 560.69M | 558.45M | 620.89M | 684.55M | 719.52M | 748.43M | 995.45M | 1.01B | 1.06B | 1.11B | 1.03B | 1.16B | 996.18M | 992.44M | 989.58M |
Total Assets | 2.63B | 2.66B | 1.71B | 1.84B | 1.92B | 1.79B | 1.9B | 1.26B | 1.34B | 1.61B | 1.71B | 1.58B | 1.8B | 1.8B | 1.94B | 2.01B | 2.06B | 2.11B |
Account Payables | 26.5M | 15.15M | 17.27M | 13.29M | 24.28M | 27.46M | 6.04M | 19.15M | 25.74M | 26.31M | 27.27M | 20.86M | 22.88M | 18.36M | 23.03M | 21.46M | 20.82M | 19.11M |
Deferred Revenue | 9.76M | 12.83M | 5.5M | n/a | 3.7M | 1.83M | 801K | 1.22M | 332.82M | 214K | 1.35M | n/a | n/a | n/a | 265.75M | 230.87M | 215.1M | 1.89M |
Short-Term Debt | 17.08M | n/a | 257.82M | n/a | n/a | 16.52M | 194.31M | 14.31M | 12.43M | n/a | 72.15M | 11.48M | 160.98M | 158.86M | 149.54M | 202.01M | 44.34M | 33.15M |
Other Current Liabilities | 534.54M | 341.13M | 120.22M | 524.65M | 301.49M | 475.32M | 139.82M | 369.51M | 213.61M | 361.51M | 126.46M | 329.89M | 329.02M | 256.37M | 269.48M | 192.72M | 184.14M | 159M |
Total Current Liabilities | 627.81M | 595.39M | 580.98M | 610.71M | 609.8M | 574.55M | 603.1M | 492.12M | 476.34M | 441.63M | 406.24M | 420.08M | 567.37M | 476.78M | 509.35M | 465.26M | 290.96M | 250.95M |
Long-Term Debt | 371.08M | 285.71M | 2.11B | 285.11M | 284.81M | 284.51M | 1.9B | 573.17M | 572.64M | 572.09M | 1.26B | 282.75M | 282.46M | 282.18M | 281.89M | 952.15M | 1.1B | 1.09B |
Other Long-Term Liabilities | 1.84B | 1.87B | 22.23M | 1.85B | 1.85B | 1.65B | 36.44M | 696.61M | 698.87M | 832.22M | 166.64M | 842.57M | 843.31M | 903M | 914.59M | 253.38M | 242.59M | 241.89M |
Total Long-Term Liabilities | 2.21B | 2.25B | 2.22B | 2.29B | 2.29B | 2.11B | 2.12B | 1.44B | 1.44B | 1.62B | 1.65B | 1.38B | 1.42B | 1.41B | 1.17B | 1.44B | 1.57B | 1.57B |
Total Liabilities | 2.84B | 2.84B | 2.8B | 2.9B | 2.9B | 2.68B | 2.72B | 1.93B | 1.92B | 2.07B | 2.05B | 1.8B | 1.99B | 1.89B | 1.94B | 1.9B | 1.86B | 1.82B |
Total Debt | 388.17M | 389.62M | 2.47B | 400.2M | 395.5M | 421.44M | 2.23B | 704.35M | 702.68M | 701.17M | 1.46B | 415.03M | 599.47M | 532.14M | 431.43M | 535.54M | 536.43M | 536.98M |
Common Stock | 78K | 78K | 77K | 76K | 76K | 76K | 75K | 75K | 75K | 73K | 72K | 71K | 71K | 71K | 71K | 70K | 70K | 70K |
Retained Earnings | -2.85B | -2.78B | -3.65B | -3.58B | -3.47B | -3.38B | -3.28B | -3.13B | -2.99B | -2.8B | -2.66B | -2.49B | -2.38B | -2.22B | -2.1B | -1.95B | -1.82B | -1.7B |
Comprehensive Income | 7.36M | -13.95M | -25.89M | -4.34M | -16.5M | -5.56M | -1.28M | 9.61M | -1.43M | -1.59M | 4.8M | 36.2M | 10.25M | -18.61M | -24.28M | -32.96M | -46.09M | -38.74M |
Shareholders Equity | -206.55M | -185.76M | -1.1B | -1.05B | -980.18M | -893.92M | -818.55M | -670.81M | -579.27M | -457.56M | -347.09M | -226.9M | -182.22M | -90.58M | 1.44M | 104.93M | 196.58M | 292.58M |
Total Investments | 987.45M | 546.95M | 359.99M | 487.36M | 452.28M | 352.73M | 299.02M | 145.91M | 129.55M | 118.81M | 130.87M | 184.01M | 347.39M | 443.62M | 583.66M | 678.13M | 769.73M | 841.77M |